Litcius/Paper detail

88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer

Marcus Schmidt, Isabel Vogler, Evelyna Derhovanessian, Tana Omokoko, Eva Godehardt, Sebastian Attig, Andrea Cortini, Sebastian Newrzela, JOCELYN GRUTZNER, Stefanie Bolte, Daniël Langer, Michael Eichbaum, Henrik Lindman, Steve Pascolo, Andreas Schneeweiß, Tobias Sjöblom, Özlem Türeci, Uğur Şahin

2020Annals of Oncology34 citationsDOI

Topics & Concepts

ELISPOTMedicineImmunogenicityImmunologyTriple-negative breast cancerT cellAntigenImmune systemImmunotherapyCD8T-cell receptorAdjuvantBreast cancerCancerInternal medicineImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersNanoplatforms for cancer theranostics
88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer | Litcius